1. Home
  2. MEG vs ORIC Comparison

MEG vs ORIC Comparison

Compare MEG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$24.71

Market Cap

943.9M

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.18

Market Cap

783.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
ORIC
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
943.9M
783.0M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
MEG
ORIC
Price
$24.71
$8.18
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$33.50
$19.50
AVG Volume (30 Days)
338.1K
1.4M
Earning Date
11-04-2025
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$826,323,000.00
N/A
Revenue This Year
$19.70
N/A
Revenue Next Year
$2.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.77
N/A
52 Week Low
$10.51
$3.90
52 Week High
$32.00
$14.93

Technical Indicators

Market Signals
Indicator
MEG
ORIC
Relative Strength Index (RSI) 39.77 28.73
Support Level $25.63 $7.96
Resistance Level $26.43 $8.44
Average True Range (ATR) 0.95 0.43
MACD -0.12 0.01
Stochastic Oscillator 0.68 11.01

Price Performance

Historical Comparison
MEG
ORIC

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: